13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q1 2019. See the latest, Q2 2026 →
Reported value
$441.54B
+11% on the quarter before
Positions
2,023
205 new · 211 sold out
Top 10
14.3%
of the value
Est. gain
+$49.70B
on stocks held all quarter
Est. return
+13.5%
on those stocks since Q4 2018
Positions as of Mar 31, 2019, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 27% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2018. Striped tiles are options.
Largest buys
Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Meta~$865.6MAdded · 0.2% → 0.4%+5,192,666 shares
- Home Depot Inc~$778.2MAdded · 0.6% → 0.8%+4,055,289 shares
- Elanco Animal Health Inc~$653.1MAdded · 0.0% → 0.2%+20,363,544 shares
- Anthem Inc~$614.0MAdded · 0.4% → 0.5%+2,139,472 shares
- Steris Plc~$580.7MNew · 0.0% → 0.1%+4,535,771 shares
- Raytheon Co~$531.9MAdded · 0.0% → 0.2%+2,921,002 shares
- Procter And Gamble Co~$519.5MAdded · 0.4% → 0.5%+4,993,033 shares
- Intel~$465.3MAdded · 0.8% → 0.9%+8,665,499 shares
- Coca Cola Co~$426.3MAdded · 0.9% → 0.9%+9,098,307 shares
- Alibaba~$419.9MAdded · 0.5% → 0.7%+2,301,412 shares
Largest sells
Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Eli Lilly~$1.25BCut · 1.3% → 1.1%−9,625,485 shares
- Canadian Nat Res Ltd~$650.2MCut · 0.2% → 0.1%−23,645,473 shares
- Union Pacific Corp~$646.8MCut · 0.8% → 0.8%−3,868,179 shares
- Exxon Mobil Corp~$535.3MCut · 1.0% → 1.0%−6,625,339 shares
- Steris Plc~$506.8MSold out · 0.1% → 0.0%−4,742,843 shares
- Starbucks Corp~$499.2MCut · 0.1% → 0.0%−6,714,777 shares
- Unitedhealth Group Inc~$480.5MCut · 1.9% → 1.6%−1,943,474 shares
- Bristol Myers Squibb Co~$465.8MCut · 1.8% → 1.4%−9,763,531 shares
- Medtronic Plc~$464.0MCut · 1.7% → 1.4%−5,094,261 shares
- Schlumberger Ltd~$452.0MCut · 0.1% → 0.1%−10,374,961 shares
Holdings
As of Mar 31, 2019. Changes are in shares against Dec 31, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −0.6% · price +16.1% | 2.1% | $9.35B | +$1.30B | ||||||||
| Verizon Communications IncCOM · shares −3.4% · price +5.2% | 1.6% | $7.12B | +$350.4M | ||||||||
| Unitedhealth Group IncCOM · shares −6.3% · price −0.7% | 1.6% | $7.09B | −$53.4M | ||||||||
| Medtronic PlcSHS · shares −6.9% · price +0.1% | 1.4% | $6.23B | +$8.2M | ||||||||
| Bristol Myers Squibb CoCOM · shares −7.2% · price −8.2% | 1.4% | $5.99B | −$536.0M | ||||||||
| Bank Amer CorpCOM · shares +0.04% · price +12.0% | 1.3% | $5.86B | +$625.9M | ||||||||
| Jpmorgan Chase & CoCOM · shares −3.1% · price +3.7% | 1.3% | $5.69B | +$202.8M | ||||||||
| American TowerCOM · shares −5.9% · price +24.6% | 1.2% | $5.41B | +$1.07B | ||||||||
| Merck & Co IncCOM · shares −4.1% · price +8.8% | 1.2% | $5.22B | +$424.0M | ||||||||
| Chevron Corp NewCOM · shares −4.3% · price +13.2% | 1.1% | $5.00B | +$584.7M | ||||||||
| Comcast Corp NewCL A · shares +1.8% · price +17.4% | 1.1% | $4.92B | +$716.3M | ||||||||
| Eli LillyCOM · shares −21% · price +12.1% | 1.1% | $4.76B | +$515.1M | ||||||||
| AmazonCOM · shares +2.7% · price +18.6% | 1.1% | $4.68B | +$713.4M | ||||||||
| AlphabetCAP STK CL A · shares −3.1% · price +12.6% | 1.0% | $4.55B | +$510.5M | ||||||||
| Exxon Mobil CorpCOM · shares −11% · price +18.5% | 0.96% | $4.22B | +$658.2M | ||||||||
| Chubb LimitedCOM · shares −4.2% · price +8.4% | 0.95% | $4.21B | +$327.9M | ||||||||
| IntelCOM · shares +13% · price +14.4% | 0.89% | $3.95B | +$438.8M | ||||||||
| Lockheed Martin CorpCOM · shares +5.6% · price +14.6% | 0.87% | $3.85B | +$464.8M | ||||||||
| Coca Cola CoCOM · shares +13% · price −1.0% | 0.86% | $3.82B | −$35.5M | ||||||||
| CiscoCOM · shares −4.1% · price +24.6% | 0.85% | $3.74B | +$738.0M | ||||||||
| Abbott LabsCOM · shares +12% · price +10.5% | 0.84% | $3.69B | +$314.3M | ||||||||
| Pepsico IncCOM · shares −0.2% · price +10.9% | 0.83% | $3.67B | +$361.1M | ||||||||
| Allergan PlcSHS · shares −1.1% · price +9.5% | 0.82% | $3.61B | +$314.3M | ||||||||
| Union Pacific CorpCOM · shares −16% · price +21.0% | 0.78% | $3.44B | +$595.5M | ||||||||
| Pnc Finl Svcs Group IncCOM · shares −3.4% · price +4.9% | 0.78% | $3.43B | +$160.7M | ||||||||
| Total · 2,023 positions | 100% | $441.54B | +$49.70B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2018 to Q1 2019: 1,759 stocks held throughout, up $49.70B (+13.5%).
- Microsoft+$1.30B+16%
- American Tower+$1.07B+25%
- Cisco+$738.0M+25%
- Danaher Corporation+$716.8M+28%
- Comcast Corp New+$716.3M+17%
- Pfizer Inc−$88.8M−3%
- Centene Corp Del−$146.4M−54%
- Biogen Inc−$336.2M−21%
- Cvs Health Corp−$342.6M−18%
- Bristol Myers Squibb Co−$536.0M−8%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |